ES2182120T3 - Heteroariloxietilaminas como ligandos del receptor 5-ht1a. - Google Patents
Heteroariloxietilaminas como ligandos del receptor 5-ht1a.Info
- Publication number
- ES2182120T3 ES2182120T3 ES97943000T ES97943000T ES2182120T3 ES 2182120 T3 ES2182120 T3 ES 2182120T3 ES 97943000 T ES97943000 T ES 97943000T ES 97943000 T ES97943000 T ES 97943000T ES 2182120 T3 ES2182120 T3 ES 2182120T3
- Authority
- ES
- Spain
- Prior art keywords
- heteroariloxietilaminas
- receiver
- ligandos
- ht1a
- antiemetics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A NUEVAS HETEROARILOXIETILAMINAS QUE TIENEN UNA GRAN AFINIDAD PARA EL RECEPTOR 5 - HT SUB,1A , A PROCEDIMIENTOS DE PREPARACION, A COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y A SU UTILIZACION COMO MEDICAMENTOS Y PARTICULARMENTE COMO INHIBIDORES DE SECRECION DE ACIDO GASTRICO O COMO ANTIEMETICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9611798A FR2753968B1 (fr) | 1996-09-27 | 1996-09-27 | Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2182120T3 true ES2182120T3 (es) | 2003-03-01 |
Family
ID=9496126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97943000T Expired - Lifetime ES2182120T3 (es) | 1996-09-27 | 1997-09-26 | Heteroariloxietilaminas como ligandos del receptor 5-ht1a. |
Country Status (21)
Country | Link |
---|---|
US (1) | US6063784A (es) |
EP (1) | EP0929525B1 (es) |
JP (1) | JP2001503393A (es) |
AR (1) | AR008486A1 (es) |
AT (1) | ATE223380T1 (es) |
AU (1) | AU731459B2 (es) |
BR (1) | BR9711560A (es) |
CA (1) | CA2267247C (es) |
DE (1) | DE69715223T2 (es) |
DK (1) | DK0929525T3 (es) |
ES (1) | ES2182120T3 (es) |
FR (1) | FR2753968B1 (es) |
HU (1) | HUP0001189A3 (es) |
IL (1) | IL128917A (es) |
MY (1) | MY118992A (es) |
NO (1) | NO311935B1 (es) |
NZ (1) | NZ334623A (es) |
PL (1) | PL190221B1 (es) |
RU (1) | RU2176639C2 (es) |
TW (1) | TW425390B (es) |
WO (1) | WO1998013349A2 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4507398B2 (ja) * | 1999-12-06 | 2010-07-21 | 宇部興産株式会社 | 3−ハロメチルオキセタン化合物の合成方法 |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
US5240800A (en) * | 1991-07-29 | 1993-08-31 | Eastman Kodak Company | Near-infrared radiation sensitive photoelectrographic master and imaging method |
GB9507288D0 (en) * | 1995-04-07 | 1995-05-31 | Sod Conseils Rech Applic | Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors |
-
1996
- 1996-09-27 FR FR9611798A patent/FR2753968B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-24 AR ARP970104385A patent/AR008486A1/es unknown
- 1997-09-25 MY MYPI97004469A patent/MY118992A/en unknown
- 1997-09-26 AT AT97943000T patent/ATE223380T1/de not_active IP Right Cessation
- 1997-09-26 WO PCT/FR1997/001691 patent/WO1998013349A2/fr active IP Right Grant
- 1997-09-26 IL IL12891797A patent/IL128917A/xx not_active IP Right Cessation
- 1997-09-26 DK DK97943000T patent/DK0929525T3/da active
- 1997-09-26 ES ES97943000T patent/ES2182120T3/es not_active Expired - Lifetime
- 1997-09-26 CA CA002267247A patent/CA2267247C/fr not_active Expired - Fee Related
- 1997-09-26 EP EP97943000A patent/EP0929525B1/fr not_active Expired - Lifetime
- 1997-09-26 TW TW086114116A patent/TW425390B/zh not_active IP Right Cessation
- 1997-09-26 BR BR9711560A patent/BR9711560A/pt active Search and Examination
- 1997-09-26 PL PL97332480A patent/PL190221B1/pl not_active IP Right Cessation
- 1997-09-26 AU AU44637/97A patent/AU731459B2/en not_active Ceased
- 1997-09-26 RU RU99108674/04A patent/RU2176639C2/ru not_active IP Right Cessation
- 1997-09-26 NZ NZ334623A patent/NZ334623A/en unknown
- 1997-09-26 JP JP51535198A patent/JP2001503393A/ja not_active Withdrawn
- 1997-09-26 HU HU0001189A patent/HUP0001189A3/hu unknown
- 1997-09-26 US US09/254,787 patent/US6063784A/en not_active Expired - Fee Related
- 1997-09-26 DE DE69715223T patent/DE69715223T2/de not_active Expired - Lifetime
-
1999
- 1999-03-26 NO NO19991481A patent/NO311935B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE69715223D1 (de) | 2002-10-10 |
HUP0001189A2 (hu) | 2000-10-28 |
WO1998013349A2 (fr) | 1998-04-02 |
WO1998013349A3 (fr) | 1998-11-05 |
US6063784A (en) | 2000-05-16 |
NO991481D0 (no) | 1999-03-26 |
EP0929525B1 (fr) | 2002-09-04 |
NO991481L (no) | 1999-03-26 |
NO311935B1 (no) | 2002-02-18 |
AU731459B2 (en) | 2001-03-29 |
TW425390B (en) | 2001-03-11 |
IL128917A (en) | 2003-10-31 |
PL332480A1 (en) | 1999-09-13 |
AU4463797A (en) | 1998-04-17 |
CA2267247C (fr) | 2009-05-05 |
NZ334623A (en) | 1999-09-29 |
AR008486A1 (es) | 2000-01-19 |
FR2753968B1 (fr) | 1998-11-27 |
DE69715223T2 (de) | 2003-04-30 |
FR2753968A1 (fr) | 1998-04-03 |
MY118992A (en) | 2005-02-28 |
PL190221B1 (pl) | 2005-11-30 |
IL128917A0 (en) | 2000-02-17 |
BR9711560A (pt) | 1999-08-24 |
EP0929525A2 (fr) | 1999-07-21 |
JP2001503393A (ja) | 2001-03-13 |
RU2176639C2 (ru) | 2001-12-10 |
ATE223380T1 (de) | 2002-09-15 |
DK0929525T3 (da) | 2002-12-02 |
CA2267247A1 (fr) | 1998-04-02 |
HUP0001189A3 (en) | 2001-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HN2001000027A (es) | Derivados de purina | |
HN2004000319A (es) | "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia" | |
EE200300524A (et) | Ühendid, mis on CB2-retseptori agonistid, neid sisaldavad ravimkoostised ja nimetatud ühendite kasutamine ravis | |
PT1305286E (pt) | Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento | |
ES2192301T3 (es) | Derivados de resorcinol. | |
ECSP056256A (es) | Moduladores delta-opioides triciclicos | |
AR008991A1 (es) | Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos | |
PA8510201A1 (es) | Compuestos de amida y composiciones farmacèuticas para inhibir proteinquinasas, y su modo de empleo | |
HN2002000300A (es) | Nuevos derivados de piperazina | |
BR0207543A (pt) | Quinolinona tricìclica e quinolina tricìclica como compostos moduladores de receptor de androgênio | |
HN1999000106A (es) | Compuestos heterociclicos como inhibidores de enzimas de rotamasa. | |
PA8582701A1 (es) | Nuevos compuestos de oxazol y tiazol como inhibidores del factor de crecimiento transformador (tgf) | |
PA8654701A1 (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
HN2008001393A (es) | Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
PA8452701A1 (es) | Agonistas de prostaglandinas | |
GT200000077A (es) | Sal mutua de amlodipino y atorvastatina | |
AR109263A2 (es) | Composición que comprende moxidectina | |
CR9814A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico | |
HN2002000365A (es) | Lactamas como antagonistas de taquiquininas | |
BR9909486A (pt) | Compostos calcilìticos | |
ECSP034531A (es) | Derivados sustituidos de c-ciclohexilmetilamina | |
GT200200235A (es) | Composiciones farmaceuticas y procedimientos para administrar agonistas selectivos del receptor ep2 | |
PA8469101A1 (es) | Ligandos azabiciclicos de receptores 5ht1 | |
SV1999000115A (es) | Derivados de sulfonamida ref. x-12301 | |
SV2002000005A (es) | Heterociclos 2-arilimino substituidos y composiciones que los contienen para usar como agentes que ligan el receptor de la progesterona ref. 5048p1-sv |